Form 4: Cencora EVP Campbell Reports RSU Vesting, Tax Withholding

Cencora Executive Vice President Elizabeth S. Campbell reported the vesting of restricted stock units and subsequent sale of shares for tax withholding purposes.

Summary

• Elizabeth S. Campbell, Executive Vice President of Cencora, Inc. (COR), reported transactions related to her beneficial ownership.
• On March 11, 2026, 12,623 restricted stock units (RSUs) vested, converting into an equal number of common stock shares at a price of $0.
• Concurrently, 5,842 shares of common stock were disposed of at a price of $350.3 per share to satisfy tax withholding obligations incident to the RSU vesting.
• Following these transactions, Campbell beneficially owns 30,705.667 shares of Cencora common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, reflecting routine executive compensation and tax management rather than a discretionary investment decision or a significant change in company fundamentals.

Positives

• The vesting of 12,623 restricted stock units indicates continued compensation and retention of a key executive, aligning management interests with shareholder value.

Negatives

• The disposition of 5,842 shares, while for tax purposes, reduces the executive's direct ownership slightly, though this is a standard practice.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that routine insider transactions like RSU vesting and tax-related sales are common across industries, particularly for executives receiving equity compensation. These transactions typically reflect pre-planned compensation structures rather than discretionary trading based on new information.

Comparison to Industry Standards

• StockSavvy.ai observes that the practice of granting restricted stock units (RSUs) as a component of executive compensation, followed by the sale of a portion of vested shares to cover tax liabilities, is a standard industry practice.
• Companies like Pfizer, Johnson & Johnson, and CVS Health, operating in related healthcare and pharmaceutical distribution sectors, frequently utilize similar equity compensation plans for their senior leadership, with comparable tax-related dispositions reported in their respective Form 4 filings.

Related Party Transactions

• The reported transactions involve an executive (Elizabeth S. Campbell) and the issuer (Cencora, Inc.), which constitutes a related party transaction as per SEC definitions for insider trading disclosures.

Stakeholder Impact

• Shareholders: The transactions are routine and reflect standard executive compensation practices, with minimal direct impact on existing shareholders beyond the disclosure of executive ownership changes.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

The filing details a routine insider transaction involving the vesting of restricted stock units and a subsequent sale of shares to cover tax liabilities. This is a standard event for executive compensation and does not indicate any new fundamental information about Cencora, Inc. that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing provides no new catalysts for buying or selling.

Keywords

Cencora, COR, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Elizabeth S. Campbell, Stock Transaction, Tax Withholding